MedTrace Logo

Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective Comparison

NCT06483815 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1441

Last updated 2024-07-05

No results posted yet for this study

Summary

his study aims to retrospectively compare fungal positivity rates between the SARS-CoV-2 pandemic and the post-pandemic periods. During the pandemic, Candida species had a positivity rate of 17.36%, and Aspergillus had a rate of 2.22%. Post-pandemic, these rates decreased to 9.29% and 1.00%, respectively. The overall fungal positivity rate decreased from 9.15% during the pandemic to 5.13% post-pandemic. Statistical analysis revealed a significant decrease in fungal positivity rates post-pandemic (p \< 0.01). These findings underscore the effectiveness of post-pandemic healthcare interventions and infection control strategies.

Conditions

  • Fungal Infections

Interventions

DIAGNOSTIC_TEST

Culture, İsolation

Data on patient demographics, clinical conditions, and fungal infection positivity rates were extracted from hospital records. Fungal positivity rates were calculated based on laboratory results and presented as percentages. Statistical analyses were performed using the Chi-Square test, and p-values were reported.

Sponsors & Collaborators

  • Bekir Sami Uyanık

    lead OTHER

Principal Investigators

  • Ramazan Gözüküçük · Hisar Hospital Responsible Manager

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-07-20
Completion
2024-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483815 on ClinicalTrials.gov